Tatyana Shamanskaya
Overview
Explore the profile of Tatyana Shamanskaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaurasiya K, Kireeva E, Shamanskaya T, Kachanov D, Likar Y
Clin Nucl Med
. 2023 Apr;
48(6):e316-e317.
PMID: 37083676
Primary neuroblastoma is the most common extracranial solid tumor in children and may occur anywhere along the sympathetic chain, but most commonly occur in abdominal/retroperitoneal region including the adrenal glands,...
2.
Sorrentino S, Ash S, Haupt R, Plantaz D, Schiff I, Hero B, et al.
Front Pediatr
. 2022 Oct;
10:1023498.
PMID: 36299690
Introduction: Between 5 and 15% of children with neuroblastoma (NB) present with or develop spinal canal invasion (SCI). The majority of these children have symptoms of epidural compression of spinal...
3.
Yadgarov M, Kailash C, Shamanskaya T, Kachanov D, Likar Y
Pediatr Blood Cancer
. 2022 Jun;
69(11):e29849.
PMID: 35727712
Background: In recent years, many research groups have attempted to identify a subgroup of "ultra-high risk" patients within the high-risk neuroblastoma (NB) category. The aim of our study was to...
4.
Karalexi M, Servitzoglou M, Papadakis V, Kachanov D, Cesen Mazic M, Baka M, et al.
Eur J Cancer Prev
. 2020 Sep;
32(3):254-263.
PMID: 32925511
The prognosis of children with neuroblastoma (NBL) can be dismal with significant variations depending on the stage and biology of the tumor. We assessed the event-free (EFS) and overall (OS)...
5.
Sorokin M, Kholodenko I, Kalinovsky D, Shamanskaya T, Doronin I, Konovalov D, et al.
Biomedicines
. 2020 Jun;
8(6).
PMID: 32486168
The tumor-associated ganglioside GD2 represents an attractive target for cancer immunotherapy. GD2-positive tumors are more responsive to such targeted therapy, and new methods are needed for the screening of GD2...
6.
Kachanov D, Teleshova M, Kim E, Dobrenkov K, Moiseenko R, Usychkina A, et al.
Cancer Genet
. 2014 Jun;
207(9):412-4.
PMID: 24894493
Malignant rhabdoid tumor (MRT) of the liver is a rare, highly aggressive tumor of early childhood. We report a 6-month-old boy who was diagnosed with MRT of the liver and...